Novavax Inc vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $235.5 (market cap $44.37B). The key difference: TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is far larger — about 34.1× Novavax Inc's market cap, and TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | TTWO | |
|---|---|---|
Market Cap | $1.30B | $44.37B |
Sector | Health | Media |
52-Week High | $11.19 | $262.29 |
52-Week Low | $6.22 | $189.69 |
Enterprise Value | $800.50M | $45.34B |
Trailing returns across standard periods
Latest headlines on both assets
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →